Differential cataractogenic potency of tgf-β1, β2, and -β3 and their expression in the postnatal rat eye

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 8, 1998, Pages 1399-1409

  Gordon Thomson, Clare ^a   De Iongh, Robbert U ^a   Hales, Angela M ^a   Chamberlain, Coral G ^a   McAvoy, John W ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 1; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; LENS; LENS EPITHELIUM; NEWBORN; NONHUMAN; PERINATAL PERIOD; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; RAT;

ACTINS; ANIMALS; ANIMALS, NEWBORN; CATARACT; CELLS, CULTURED; COLLAGEN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LENS, CRYSTALLINE; MICROSCOPY, PHASE-CONTRAST; ORGAN CULTURE TECHNIQUES; RATS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031748693     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Liu J, Hales AM, Chamberlain CG, McAvoy JW. Induction of cataract-like changes in rat lens epithelial explants by transforming growth factor-β. Invest Ophthalmol Vis Sci. 1994;5:388-401.
2. 1 induces lens cells to accumulate α-smooth muscle actin, a marker for subcapsular cataracts. Curr Eye Res. 1994;13:885-890.
3. Hales AM, Chamberlain CG, McAvoy JW. Cataract induction in lenses cultured with transforming growth factor-β. Invest Ophthalmol Vis Sci. 1995;36:1709-1713.
4. Schulz MW, Chamberlain CG, McAvoy JW. Inhibition of TGFβ-induced cataractous changes in lens explants by ocular media and α2-macroglobulin. Invest Ophthalmol Vis Sci. 1996;37:1509-1519.
5. Hales AM, Chamberlain CG, Murphy CR, McAvoy JW. Estrogen protects lenses against cataract induced by transforming growth factor-β (TGF-β). J Exp Med. 1997;185:273-280.
6. Eshagian J. Human posterior subcapsular cataracts. Trans Ophthalmol Soc UK. 1982;102:364-368.
7. 1 in transgenic mice causes anterior sub-capsular cataracts (ARVO Abstracts]. Invest Ophthalmol Vis Sci. 1997;38:S934. Abstract nr 4350.
8. Laiho M, Keski-Oja J. Transforming growth factors-β as regulators of cellular growth and phenotype. Crit Rev Oncog. 1992;3:1-26.
9. Miyazono K, Ichijo H, Heldin C-H. Transforming growth factor-β: latent forms, binding proteins and receptors. Growth Factors. 1993;8:11-22.
10. Rifkin DB, Kojima S, Abe M, Harpel JG. Transforming growth factor-β. Structure, function, and formation. Thromb Haemost. 1993;70:177-179.
11. Kingsley DM. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 1994;8:133-146.
12. Connor TB, Roberts AB, Sporn MB, et al. Correlation of fibrosis and transforming growth factor-type 2 levels in the eye. J Clin Invest. 1989;83:1661-1666.
13. Granstein RD, Staszewski R, Knisely TL, et al. Aqueous humour contains transforming growth factor-β and a small (<3500 daltons) inhibitor of thymocyte proliferation. J Immunol. 1990;144:3021-3027.
14. Jampel HD, Roche N, Stark WJ, Roberts A. Transforming growth factor-β in human aqueous humor. Curr Eye Res. 1990;9:963-969.
15. 2 levels in aqueous humor during uveitis. Invest Ophthalmol Vis Sci. 1994;35:3702-3710.
16. Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 1991;32: 2201-2211.
17. Tripathi RC, Borisuth NSC, Tripathi BJ. Growth factors in the aqueous humor and their therapeutic implications in glaucoma and anterior segment disorders of the human eye. Drug Dev Res. 1990;22:1-23.
18. 2 in human aqueous humor on bovine epithelial cell proliferation. Invest Ophthalmol Vis Sci. 1994;35:3408-3412.
19. Gatherer D, Ten Dijke P, Baird DT, Akhurst RJ. Expression of TGF-β isoforms during first trimester human embryogenesis. Development. 1990;110:445-460.
20. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI. Immunohistochemical localization of TGFβ1, TGFβ2, and TGFβ3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol. 1991;115:1091-1105.
21. Millan FA, Denhez F, Kondaiah P, Akhurst RJ. Embryonic gene expression patterns of TGF β1, β2 and β3 suggest different developmental functions in vivo. Development. 1991;111:131-144.
22. Lutty GA, Merges C, Threlkeld AB, Crone S, McLeod DS. Heterogeneity in localization of isoforms of TGF-β in human retina, vitreous, and choroid. Invest Ophthalmol Vis Sci. 1993;34:477-487.
23. 3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci. 1993;34:23-30.
24. Nishida K, Kinoshita S, Yokoi N, Kaneda M, Hashimoto K. Transforming growth factor betas in human corneas [ARVO Abstracts]. Invest Ophthalmol Vis Sci. 1993;34:1301. Abstract nr 2948.
25. 1 and secrete this cytokine. Invest Ophthalmol Vis Sci. 1993;34:2562-2569.
26. 3 immunoreactivity within the ciliary epithelium. Invest Ophthalmol Vis Sci. 1994;35:453-457.
27. Anderson DH, Guerin CJ, Hageman GS, Pfeffer BA, Flanders KC. Distribution of transforming growth factor-β isoforms in the mammalian retina. J Neurosci Res. 1995;42:63-79.
28. 2. Mol Endocrinol. 1989;3:1977-1986.
29. Randall LA, Wadhwa M, Thorpe R, Mire-Sluis AR. A novel, sensitive bioassay for transforming growth factor β. J Immunol Methods. 1993;164:61-67.
30. Hales AM, Chamberlain CG, McAvoy JW. Measurement of lens epithelial cell migration on a laminin substratum using image analysis. J Comput Assist Microsc. 1992;4:135-139.
31. 2 in immunoassays. Growth Factors. 1990;3:45-52.
32. 1, β2 and β3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem. 1996;271: 10188-10193.
33. Click AB, McCune BK, Abdulkarem N, et al. Complex regulation of TGF-β expression by retinoic acid in the vitamin A-deficient rat. Development. 1991;111:1081-1086.
34. Barnard JA, Warwick GJ, Gold LI. Localization of transforming growth factor β isoforms in the normal murine small intestine and colon. Gastroenterology. 1993;105:67-73.
35. Miller DA, Lee A, Pelton RW, Chen EY, Moses HL, Derynck R. Murine transforming growth factor-β 2 cDNA sequence and expression in adult tissues and embryos. Mol Endocrinol. 1989;3: 1108-1114.
36. Miller DA, Lee A, Matsui Y, Chen EY, Moses HL, Derynck R. Complementary DNA cloning of the murine transforming growth factor-β3 (TGFβ 3) precursor and the comparative expression of TGFβ 3 and TGFβ 1 messenger RNA in murine embryos and adult tissues. Mol Endocrinol. 1989;3:1926-1934.
37. de Iongh RU, Lovicu FJ, Hanneken A, Baird A, McAvoy JW. FGF Receptor-1 (flg) expression is correlated with fibre differentiation during rat lens morphogenesis and growth. Dev Dyn. 1996;206: 412-426.
38. McAvoy JW, Chamberlain CG, Liu J, Hales AM. Transforming growth factor-β induces cataract-like changes in lens epithelial explants [ARVO Abstracts]. Invest Ophthalmol Vis Sci. 1994;35: 1494. Abstract nr 1103.
39. Chiefetz S, Hernandez H, Laiho M, ten Dijke P, Iwata KK, Massague J. Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J Biol Chem. 1990;265:20533-20538.
40. Qian SW, BurmesterJK, Sun PD, et al. Characterization of mutated transforming growth factor-βs which possess unique biological properties. Biochemistry. 1994;33:12298-12304.
41. Danielpour D, Sporn MB. Differential inhibition of transforming growth factor β1 and β2 activity by α2-macroglobulin. J Biol Chem. 1990;265:6973-6977.
42. Crookston KP, Webb DJ, Wolf BB, Gonias SL. Classification of α2-macroglobulin-cytokine interactions based on affinity of non-covalent association in solution under apparent equilibrium conditions. J Biol Chem. 1994;269:1533-1540.
43. 1-3 and their relative potencies for cataractogenesis [ARVO Abstracts). Invest Ophthalmol Vis Sci. 1997;38:S957. Abstract nr 4435.
44. Lehnert SA, Akhurst RJ. Embryonic expression pattern of TGF beta type-I RNA suggests both paracrine and autocrine mechanisms of action. Development. 1988;104:263-273.
45. McGahan MC, Davidson MG, Nasisse MP, Fleisher LN, Allen JB. The lens influences intraocular fluid levels of transforming growth factor-β2. [ARVO Abstracts]. Invest Ophthalmol Vis Sci. 1996;37: S980. Abstract nr 4490.
46. de Iongh RU, Gordon-Thomson C, Chamberlain CG, McAvoy JW. Age-related competence of TGF-β response in rat lens epithelium correlates with receptor expression [ARVO Abstracts]. Invest Ophthalmol Vis Sci. 1996;37:S983. Abstract nr 4507.
47. Ueda Y, Chamberlain CG, Satoh K, McAvoy JW. Regulation of αA-crystallin promoter by FGF and TGF-β (ISER Abstracts). Exp Eye Res. 1996;63:S15.